July 1-2, 2013 | London
MBHB partner Kevin Noonan, Ph.D. is a featured presenter and MBHB partner Paul Tully, Ph.D. is a featured moderator at the Tech Transfer Summit (“TTS”) Europe 2013. Details for their programs are as follows:
July 1 – 3:30 p.m.
KOL Insight: The most important trends & developments in global biotech IP, or “what the hell is happening in the US?”
Presenter:
Kevin Noonan, Ph.D., Partner, McDonnell Boehnen Hulbert & Berghoff LLP
July 1 – 3:45 p.m.
What are the key new issues with regard to the European Patent (will anything really change?), what is the impact of recent US litigation, and how to best manage IP and prioritize IP strategies?
Moderator:
Paul Tully, Ph.D., Partner, McDonnell Boehnen Hulbert & Berghoff LLP
Presenters:
Kevin Noonan, Ph.D., Partner, McDonnell Boehnen Hulbert & Berghoff LLP
Denise Hirsh, Head of Intellectual Property, Inserm Transfert
Philippe Jacobs, European Patent Attorney, UGent Tech Transfer
Cyra Nargolwalla, Partner, Cabinet Plasseraud
About TTS Europe 2013
The premier meeting and benchmark for technology transfer events in the biotechnology sector, the TTS Europe is the European flagship event of the Global Tech Transfer Summit Initiative and is organized together with a consortium of the leading technology transfer organizations from both the public and private sectors in the UK and from across Europe and the world, and with the support of key industry and leading technology transfer, IP, licensing and other specialized organizations. Join international experts and executives from industry, finance and IP in sourcing the best technology from across Europe and the pioneering tech transfer and early-stage biotech venture meeting.
Sponsored by: TTS Ltd.
View complete details including registration at http://www.techtransfersummit.com/Europe2013/
